No Detail Found!

Is mucormycosis an addition to the pandemic spectrum: an observational study

Author(s)
Muhammad Ilyas Ameer ud Din Medical College, Post Graduate Medical Institute, Lahore, Pakistan.
Ghulam Dastagir Khan Ameer ud Din Medical College, Post Graduate Medical Institute, Lahore, Pakistan.
Ghazala Rubi Ameer ud Din Medical College, Post Graduate Medical Institute, Lahore, Pakistan.
Hurtamina Khan Ameer ud Din Medical College, Post Graduate Medical Institute, Lahore, Pakistan.
Adeel Niaz Ameer ud Din Medical College, Post Graduate Medical Institute, Lahore, Pakistan
Waqas Javaid Ameer ud Din Medical College, Post Graduate Medical Institute, Lahore, Pakistan.
Abstract
Background and Objective: A concerning increase in occurrences of COVID-19-associated mucormycosis (CAM), has been reported worldwide in people who are coping with COVID-19 disease. Despite this apparent correlation, the exact association is yet unknown. To ascertain the degree to which mucormycosis and coronavirus illnesses are associated, this study was conducted to analyze the relationship between COVID-19 and mucormycosis infection. Methods: This observational study examined 35 individuals who had been diagnosed with mucormycosis at Lahore General Hospital, Lahore, Pakistan. The relationship between mucormycosis and coronavirus disease was determined by analyzing the patient's demographics, gender, COVID-19 status, and co-morbidities. Results: The mean age of the enrolled patients was 49.40 ± 13.511 years with the majority (54.3%) being male. A total of 25.7% had confirmed COVID-19-positive disease. Notably, diabetes mellitus (DM) was the predominant co-morbidity in a significant proportion of patients (74.3%), followed by comorbidity of DM with chronic kidney disease (11.4%), chronic liver disease (8.6%), and hypertension (5.7%). The presence of co-morbidities and COVID-19 were significantly correlated (p 0.05). Conclusion: In conclusion, mucormycosis could be an additional aspect of the pandemic's spectrum. The data from our study supports this claim since a significant percentage of the patients with mucormycosis had a positive COVID-19 disease concomitantly.
Publication Details
Page(s) 32-36
Published Journal: Biomedica, Volume: 40, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
COVID-19, Diabetes mellitus, Pandemic, comorbidities, Diabetes mellitus, Covid-19, Mucormycosis, COVID-19-associated mucormycosis (CAM)
0

Citations

0

Downloads

38

Views